Inovio Pharmaceuticals Inc. (INO) Soars 33.02% on February 01

Equities Staff  |

Inovio Pharmaceuticals Inc. (INO) had a good day on the market for Monday February 01 as shares jumped 33.02% to close at $16.96. About 93.84 million shares traded hands on 460,190 trades for the day, compared with an average daily volume of n/a shares out of a total float of 204.55 million. After opening the trading day at $13.76, shares of Inovio Pharmaceuticals Inc. stayed within a range of $18.20 to $13.30.

With today's gains, Inovio Pharmaceuticals Inc. now has a market cap of $3.47 billion. Shares of Inovio Pharmaceuticals Inc. have been trading within a range of $33.80 and $3.15 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals Inc. is based out of Plymouth Meeting, PA and has some 190 employees. Its CEO is J. Joseph Kim.

For a complete fundamental analysis of Inovio Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for INO.

Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start

Inovio Pharmaceuticals Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Inovio Pharmaceuticals Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: INO’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

President Biden's New Alliance With Australia and Britain Angers France and European Union
California Governor Newsom Signs Affordable Housing Law
COVID-19 Surge in Idaho Forcing Statewide Health Care Rationing
JPMorgan Launching Its First Overseas Digital Bank in United Kingdom Next Week
Federal Reserve Reviewing Ethics Policies in Wake of Prolific Trading Disclosed by Two Senior Officials
Chinese Property Developer Evergrande Not 'Too Big to Fail' — Global Times
August Retail Sales Rebound 0.7%, Surprising Economists After July Plunge
UN Report Shows COVID-19 Has Not Slowed Pace of Climate Change



Market Movers

Sponsored Financial Content